Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline

NCT01642914 is registered in ClinicalTrials.gov with Forest Laboratories as lead sponsor.

NCT NCT01642914
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01642914 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline
Lead sponsor
Forest Laboratories
Phase
Phase 3
Overall status
Completed
Start date
August 31, 2012
Completion date
August 31, 2013
Enrollment
487 (actual)
Sites
151

Conditions

As the registry lists them; a condition with its own page is linked.

chronic constipation, constipation